GB731933A - Liquid preparations of therapeutically active substances for sub-cutaneous or intramuscular injection - Google Patents

Liquid preparations of therapeutically active substances for sub-cutaneous or intramuscular injection

Info

Publication number
GB731933A
GB731933A GB10348/52A GB1034852A GB731933A GB 731933 A GB731933 A GB 731933A GB 10348/52 A GB10348/52 A GB 10348/52A GB 1034852 A GB1034852 A GB 1034852A GB 731933 A GB731933 A GB 731933A
Authority
GB
United Kingdom
Prior art keywords
active substances
cutaneous
sub
polyoxyethylene glycol
polyoxyethylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB10348/52A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
E FOUGERA AND Co
E Fougera and Co Inc
Original Assignee
E FOUGERA AND Co
E Fougera and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E FOUGERA AND Co, E Fougera and Co Inc filed Critical E FOUGERA AND Co
Publication of GB731933A publication Critical patent/GB731933A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

A clear injectible liquid comprises a solution of a physiologically active substance in a mixture of water with at least one of the substances (a) polyoxyethylene glycol, (b) a polyoxyethylene glycol derivative of a partial ester of a polyhydric alcohol with a long chain fatty acid, (c) propylene glycol, the proportions of the ingredients in said solvent being such that the solution is stable, but precipitates the active substances on injection. Glycerol may be used in conjunction with propylene glycol. The active substances may be hormones, p anesthetics, antibiotics and histamin-antagonizing agents, many examples of all of which are given. Polyoxyethylene glycols of mol. weight of from 200-4000 may be employed. Polyoxyethylene glycol derivatives of the following esters are mentioned: sorbitan monolaurate, monopalmitate, monostearate, monooleate, trioleate, sorbitol hexastearate and the corresponding mannitan derivatives. Specifications 667,010 and 674,784 are referred to.
GB10348/52A 1951-04-28 1952-04-24 Liquid preparations of therapeutically active substances for sub-cutaneous or intramuscular injection Expired GB731933A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US731933XA 1951-04-28 1951-04-28

Publications (1)

Publication Number Publication Date
GB731933A true GB731933A (en) 1955-06-15

Family

ID=22112293

Family Applications (1)

Application Number Title Priority Date Filing Date
GB10348/52A Expired GB731933A (en) 1951-04-28 1952-04-24 Liquid preparations of therapeutically active substances for sub-cutaneous or intramuscular injection

Country Status (1)

Country Link
GB (1) GB731933A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0145493A2 (en) 1983-12-14 1985-06-19 The Upjohn Company 11-Difluoromethyl and 11-fluoromethylene steroids
EP0197308A2 (en) * 1985-03-11 1986-10-15 Morton Shulman Composition and method for producing prolonged pain relief
EP1446103A2 (en) * 2001-10-19 2004-08-18 Idexx Laboratories, Inc. Injectable compositions for the controlled delivery of pharmacologically active compound
EP1617847A2 (en) * 2003-04-18 2006-01-25 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0145493A2 (en) 1983-12-14 1985-06-19 The Upjohn Company 11-Difluoromethyl and 11-fluoromethylene steroids
EP0197308A2 (en) * 1985-03-11 1986-10-15 Morton Shulman Composition and method for producing prolonged pain relief
EP0197308A3 (en) * 1985-03-11 1987-08-26 Morton Shulman Composition and method for producing prolonged pain relief
JPH064534B2 (en) 1985-03-11 1994-01-19 モートン シュルマン Combination drug for long-term pain relief
EP1446103A2 (en) * 2001-10-19 2004-08-18 Idexx Laboratories, Inc. Injectable compositions for the controlled delivery of pharmacologically active compound
EP1446103A4 (en) * 2001-10-19 2011-01-12 Idexx Lab Inc Injectable compositions for the controlled delivery of pharmacologically active compound
EP1617847A2 (en) * 2003-04-18 2006-01-25 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
EP1617847A4 (en) * 2003-04-18 2011-08-10 Idexx Lab Inc Methods for the controlled delivery of pharmacologically active compounds

Similar Documents

Publication Publication Date Title
US3849569A (en) Composition containing procaine penicillin
GB1066459A (en) Diagnostic aid
GB731933A (en) Liquid preparations of therapeutically active substances for sub-cutaneous or intramuscular injection
ES291443A1 (en) A procedure for preparing vitamin compositions (Machine-translation by Google Translate, not legally binding)
NL113277C (en) PROCESS FOR THE PREPARATION OF ORGANIC CARBONIC ACID ESTERS FROM SALTS OF CARBONIC ACIDS AND ALKYL HALOGENIDES
US2457188A (en) Benzocaine solution
GB2000025A (en) Nitroimidazole formulations
BE603518A (en) Derivatives of 4-halo-3-sulfamoylbenzoic acids and processes for their preparation
US4600582A (en) Therapeutic treatment
Hellbaum et al. Action of estrogen on release of hypophyseal luteinizing hormone
ES353413A1 (en) Quinoline Derivatives
GB490942A (en) Process for the manufacture of highly concentrated solutions of fat soluble hormones and derivatives thereof
GB850923A (en) Improvements in or relating to nail varnish removers
ES194153A1 (en) A PROCEDURE FOR OBTAINING CELLULOSE ESTERS
GB619065A (en) Improvements in or relating to a method of stabilising an aqueous solution of ascorbic acid (vitamin c)
GB1077039A (en) A choline derivative and therapeutic compositions containing it
CA596932A (en) Carboxylic acid and ester derivatives of 8-alkylnortropanes and methods for their preparation
GB931420A (en) Injectable pharmaceutical compositions comprising 1-ethyl-1-methylpropyl carbamate
GB942876A (en) Improvements in or relating to piperidylidene-thiaxanthene
GB712505A (en) Improvements in and relating to therapeutic aqueous colloidal preparations containing calcium
IT1031094B (en) STABLE COMPOSITION AND PROCEDURES TO INHIBIT THE POLYM ERIZATION OF UNSATURATED CARBOXYLIC ACID ESTERS
ES203915A2 (en) A procedure for the obtaining of highly concentrated injectable preparations of steroid hormones (Machine-translation by Google Translate, not legally binding)
ES2075240T3 (en) PROCEDURE TO FORM A STABLE COLLOID DISPERSION.
GB642971A (en) Improvements in therapeutic preparations
JPS55164621A (en) Stable solubilized liquid of vitamin k